RumbleOn, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by RumbleOn, Inc. on June 28, 2018, regarding events occurring at the Company's 2018 Annual Meeting of Stockholders held on June 25, 2018. The Company is incorporated in Nevada and is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance, stockholder voting results, and listing compliance matters.
Material Changes and Corporate Actions
- Stock Incentive Plan Amendment: Stockholders approved an amendment to the 2017 Stock Incentive Plan, increasing the authorized shares for issuance from 12% of issued and outstanding Class B Common Stock to a fixed 2,000,000 shares of Class B Common Stock.
- Articles of Incorporation Amendment: Stockholders approved an amendment to create "blank check" preferred stock, allowing the Board of Directors to fix rights, preferences, and privileges for future issuances.
- Director Election and Board Composition: Six directors were elected. Following the meeting, the Board consists of three independent members out of six total members. Consequently, the Company no longer meets the Nasdaq Listing Rule 5605 requirement for a majority of independent directors.
- Nasdaq Delisting Notice: On June 28, 2018, the Company received a letter from Nasdaq indicating the deficiency regarding independent directors. The Company has been granted a cure period to regain compliance by the earlier of its next annual shareholders' meeting or June 25, 2019 (or December 24, 2018, if the next meeting is held before that date).
Guidance, Outlook, and Risks
The filing does not contain financial guidance or management commentary on future business outlook. The primary risk disclosed is the potential delisting from Nasdaq if the Company fails to appoint a new independent director to achieve a majority independent board within the specified cure period. The Board is actively conducting a search for a new independent director.
Investor Verification Checklist
- Verify the Company's progress in appointing a new independent director to regain Nasdaq compliance before the cure period deadline.
- Review the definitive proxy statement (filed May 25, 2018) for full details on the Stock Incentive Plan amendment terms.
- Monitor future filings for the issuance of any preferred stock under the newly approved "blank check" provision.
- Confirm the final composition of the Board of Directors following the search for a new independent member.